Material Agreements

Definitive Healthcare Corp. terminated Nominating Agreement with SE VII DHC AIV, L.P. (effective 2026-04-03).

“the Company and Spectrum entered into a termination agreement that permanently and irrevocably terminated the Nominating Agreement in its entirety.”

FibroBiologics, Inc. terminated Sublease Buyout Agreement with United Fire & Casualty Co. valued at Single payment of $45,108.25; expected savings of approximately $0.8 million in future rent payments (effective 2026-04-03).

“On April 3, 2026, FibroBiologics, Inc. (the “Company”) entered into a Sublease Buyout Agreement (the “Lease Termination Agreement”) with United Fire & Casualty Co. (doing business as United Fire Group) (the “Sublandlord”) to terminate that certain Sublease Agreement, which was effective as of October 5, 2022 (“Sublease”), pursuant to which Sublandlord subleased to the Company certain premises located at the third floor of 455 E. Medical Center Blvd, Webster, County of Harris, Texas 77598.”

FibroBiologics, Inc. terminated Lease Termination Agreement with United Fire & Casualty Co. (doing business as United Fire Group) valued at $45,108.25 (effective 2026-04-03).

“On April 3, 2026, FibroBiologics, Inc. (the “Company”) entered into a Sublease Buyout Agreement (the “Lease Termination Agreement”) with United Fire & Casualty Co. (doing business as United Fire Group) (the “Sublandlord”) to terminate that certain Sublease Agreement, which was effective as of October 5, 2022 (“Sublease”)”

Atlas Energy Solutions Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $450,000,000 0.50% Convertible Senior Notes due 2031 (effective 2026-04-09).

“On April 9, 2026, Atlas Energy Solutions Inc. (the “Company”), issued $450 million aggregate principal amount of its 0.50% Convertible Senior Notes due 2031 (the “Notes”), which included the exercise in full of the Initial Purchasers’ (as defined below) option to purchase up to an additional $60 million principal amount of Notes. The Notes were issued pursuant to, and are governed by, an indenture (the “Indenture”), dated as of April 9, 2026, between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”).”

XCF Global, Inc. terminated Supply and Offtake Agreement with Phillips 66 Company (effective 2026-04-02).

“On April 2, 2026, Phillips 66 Company (“ Phillips 66 ”) delivered formal notice (the “ Notice ”) to New Rise Renewables Reno, LLC (“ New Rise ”), a wholly owned subsidiary of the Company, of the termination of the Supply and Offtake Agreement, dated May 23, 2017 (as amended, the “ Agreement ”), between New Rise and Phillips 66.”

XCF Global, Inc. entered into Term Sheet for a Renewable Fuel Tolling Agreement with BGN (effective 2026-04-09).

“On April 9, 2026, XCF Global, Inc. (the “ Company ”) entered into a Term Sheet for a Renewable Fuel Tolling Agreement with BGN, an independent global energy and commodities group, pursuant to which it is anticipated that the Company will provide the following services to BGN both at its New Rise Reno facility and, potentially, a second, future XCF facility:”

Fifth Era Acquisition Corp I entered into Business Combination Agreement with SMT Holdings Limited (effective 2026-04-07).

“As of April 7, 2026, Fifth Era Acquisition Corp I, a Cayman Islands exempted company (“ FERA ”), entered into a Business Combination Agreement (the “ Business Combination Agreement ”), by and among FERA, Miotal SPAC HoldCo, Inc., a Cayman Islands exempted company (“ Holdco ”), PENNY Merger Sub, Inc., a Cayman Islands exempted company (“ Merger Sub ”) and SMT Holdings Limited, an Abu Dhabi Global Market Private Company Limited by Shares (the “ Company ”).”

Wellgistics Health, Inc. terminated Settlement Agreement with Silverback Capital Inc. (effective 2026-04-03).

“On April 3, 2026, Wellgistics Health, Inc. (the “Company”) delivered written notice to Silverback Capital Inc. terminating that certain Settlement Agreement and Stipulation, dated January 28, 2026 (the “Settlement Agreement”), previously entered into between the Company and Silverback Capital Inc.”

Paramount Skydance Corp entered into Pro Rata Credit Agreement with Citibank, N.A. as administrative agent and collateral agent, BofA Securities, Inc., Citibank, N.A., Apollo Global Funding, LLC, Deutsche Bank Securities Inc. and Wells Fargo Securities, LLC, as joint lead arrangers and joint bookrunners, Bank of America, N.A., as syndication agent, Apollo Global Fun valued at $5.00 billion five-year revolving commitments (effective 2026-04-07).

“On April 7, 2026, PSKY entered into a Credit Agreement (the “Pro Rata Credit Agreement”) among PSKY, Citibank, N.A. as administrative agent and collateral agent, BofA Securities, Inc., Citibank, N.A., Apollo Global Funding, LLC, Deutsche Bank Securities Inc. and Wells Fargo Securities, LLC, as joint lead arrangers and joint bookrunners, Bank of America, N.A., as syndication agent, Apollo Global Funding, LLC, Deutsche Bank AG New York Branch and Wells Fargo Bank, N.A., as documentation agents, and the lenders party thereto.”

SUNation Energy, Inc. entered into Sales Agreement with Maxim Group, LLC valued at up to $3,599,586 (effective 2026-04-08).

“On April 8, 2026, SUNation Energy, Inc. (“SUNation” or the “Company”) entered into a Sales Agreement (the “Sales Agreement”) with Maxim Group, LLC (“Maxim” or the “Sales Agent”).”

FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY, INC. entered into Purchase and Sale Agreement with an affiliate of Regency Centers Corporation valued at $27,000,000 (effective 2026-04-08).

“On April 8, 2026, First Real Estate Investment Trust of New Jersey, Inc. (the “Trust” or the “Seller”) entered into a Purchase and Sale Agreement (the “Agreement”) with an affiliate of Regency Centers Corporation (the “Purchaser”), pursuant to which the Seller will sell to the Purchaser 100% of Seller’s ownership interests in the Franklin Crossing shopping center located at 814-860 Franklin Avenue, Franklin Lakes, New Jersey, (“Franklin Crossing”) in exchange for the purchase price of $27,000,000, subject to the terms and conditions of the Agreement.”

INTRUSION INC entered into Note Purchase Agreement with Streeterville Capital, LLC valued at original principal amount of $3,230,000 (effective 2026-04-06).

“On April 6, 2026, Intrusion Inc. (the “Company”) entered into a Note Purchase Agreement (the “Purchase Agreement”) with Streeterville Capital, LLC (the “Investor”). Pursuant to the Purchase Agreement, the Company issued and sold to the Investor a Secured Promissory Note (the “Note”) in the original principal amount of $3,230,000 for cash proceeds of $3,000,000 (reflecting an original issue discount of $210,000 and $20,000 in transaction expenses).”

CONSUMER PORTFOLIO SERVICES, INC. amended Credit Agreement with Capital One, N.A., and a Class B Lender valued at up to a maximum of $390 million (effective 2026-04-03).

“On April 3, 2026, Consumer Portfolio Services, Inc. ("CPS" or the "Company") and its wholly-owned subsidiary Page Eleven Funding LLC (the “Borrower”) amended a revolving credit agreement (the "Credit Agreement") and related agreements with Capital One, N.A., and a Class B Lender (the “Lenders”), all of which have been in place since October 2025.”

CAMDEN PROPERTY TRUST entered into binding term sheet with the named plaintiffs in the Class Action Litigation, individually and on behalf of the class members (together, the "Plaintiffs") valued at $53 million (effective 2026-04-07).

“On April 7, 2026, Camden Property Trust, on behalf of itself and related entities (collectively, the “Company”) entered into a binding term sheet for a settlement with the named plaintiffs in the Class Action Litigation, individually and on behalf of the class members (together, the “Plaintiffs”).”

AEHR TEST SYSTEMS entered into Equity Distribution Agreement with William Blair & Company, L.L.C. and Craig-Hallum Capital Group LLC valued at up to $60,000,000 (effective 2026-04-08).

“On April 8, 2026, AEHR Test Systems (the “Company”) entered into an equity distribution agreement (the “Equity Distribution Agreement”) with William Blair & Company, L.L.C. and Craig-Hallum Capital Group LLC (the “Agents”), in connection with the offer and sale of up to $60,000,000 of shares of the Company’s common stock, par value $0.01 per share (“ATM Shares”).”

Equitable Holdings, Inc. entered into Voting and Support Agreement with Nippon Life Insurance Company valued at Voting and Support Agreement entered into in connection with Merger Agreement (effective 2026-04-08).

“On April 8, 2026, Equitable Holdings, Inc., a Delaware corporation (“Equitable”), entered into a Voting and Support Agreement (the “Voting and Support Agreement”) with Nippon Life Insurance Company, a mutual company ( sougogaisha ) organized under the laws of Japan (“Nippon Life”), and Corebridge Financial, Inc., a Delaware corporation (“Corebridge”) in connection with the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated as of March 26, 2026, by and among Equitable, Corebridge, Mountain Holding, Inc., a newly formed Delaware corporation and wholly-owned subsidiary of Corebridge (“HoldCo”), Palisade Holding, Inc., a newly formed Delaware corporation and a wholly-owned subsidiary of HoldCo, and Marcy Holding, Inc., a newly formed Delaware corporation and a wholly-owned subsidiary of HoldCo.”

XMax Inc. entered into AI Inference Platform Deployment and Service Agreement with Cloud Alliance Inc. valued at US$400,000 (effective 2026-04-01).

“On April 6, 2026, XMax AI Inc. (" XMax AI " or the " Company "), a wholly owned subsidiary of XMax Inc., entered into an AI Inference Platform Deployment and Service Agreement (the " Agreement ") with Cloud Alliance Inc. (the " Service Provider "), effective as of April 1, 2026.”

Phio Pharmaceuticals Corp. entered into Sales Agreement with H.C. Wainwright & Co., LLC valued at $6,360,000 (effective 2026-04-08).

“On April 8, 2026, Phio Pharmaceuticals Corp. (the “Company”) entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC, as sales agent (the “Sales Agent”), pursuant to which the Company may offer and sell, from time to time, through the Sales Agent, shares of the Company’s common stock, par value $0.0001 per share (the “Shares”). The offering and sale of up to $6,360,000 of the Shares pursuant to the Sales Agreement is being registered under the Securities Act of 1933, as amended (the “Securities Act”), pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-279557), which was declared effective by the Securities and Exchange Commission (“SEC”) on July 1, 2024, which includes a base prospectus, and an accompanying prospectus supplement filed with the SEC on April 8, 2026.”

FORUM MARKETS Inc amended Second Amended and Restated Sales Agreement with Clear Street LLC and TCBI Securities, Inc., doing business as Texas Capital Securities (effective 2026-04-08).

“On April 8, 2026, the Company entered into a Second Amended and Restated Sales Agreement (the “ Second Amended and Restated Sales Agreement ”) with the Agents to cease all sales of Common Stock pursuant to the WKSI Registration Statement and WKSI Prospectus Supplement and to transition the program back to the June Registration Statement and Initial Prospectus Supplement.”

Solaris Energy Infrastructure, Inc. amended Amendment No. 1 to Senior Secured Term Loan Agreement with Goldman Sachs Bank USA valued at Amendment provides for additional commitments of $200 million, bringing total term loans to $500 mil (effective 2026-04-08).

“On April 8, 2026, Solaris Energy Infrastructure, Inc. (the “Company”) and certain of its subsidiaries entered into Amendment No. 1 (the “Amendment”) to its senior secured term loan agreement, dated as of March 16, 2026 (as amended by the Amendment, the “Term Loan Agreement”), among the Company, certain of the Company’s subsidiaries, Goldman Sachs Bank USA, as administrative agent and collateral agent, and the lenders party thereto.”

Ensysce Biosciences, Inc. entered into Securities Purchase Agreement with institutional investor valued at $2 million gross proceeds for 2,000 shares of Series B preferred stock, up to 4,363,636 shares of co (effective 2026-04-06).

“As previously reported in a Current Report on Form 8-K filed on November 17, 2025, on November 13, 2025, Ensysce Biosciences, Inc. (the “ Company ” or “ we ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) directly with an institutional investor (the “ Purchaser ”). On April 6, 2026 (the “ Closing Date ”), pursuant to the Purchase Agreement and Subsequent Purchase Notice, the Company privately issued and sold (i) 2,000 shares (the “ Shares ”) of Series B preferred stock of the Company, par value $0.0001 per share (the “ Preferred Stock ”), (ii) up to 4,363,636 shares of common stock of the Company, par value $0.0001 per share (the “ Common Stock ”) to be issued upon conversion of the Preferred Stock, and (iii) warrants to purchase up to 8,727,273 shares of Common Stock (the “ Warrants ”), all subject to adjustment, for gross proceeds of $2 million before the deduction of fees and offering expenses (the “ Offering ”).”

Zapata Quantum, Inc. entered into Securities Purchase Agreement with accredited investors valued at $6,685,000 (effective 2026-04-07).

“On April 7, 2026, Zapata Quantum, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with accredited investors, pursuant to which the Company sold and issued 6,685 shares of newly designated Series D Convertible Preferred Stock (the “Series D”), together with Warrants (the “Warrants”) to purchase 7,612,161 shares of the Company’s common stock, for gross proceeds of $6,685,000.”

Catalyst Bancorp, Inc. entered into Agreement and Plan of Share Exchange and Merger with Lakeside Bancshares, Inc. valued at $19.58 in cash per share, or $41.1 million in aggregate (effective 2026-04-07).

“On, April 7, 2026, Catalyst Bancorp, Inc., a Louisiana corporation ("Catalyst Bancorp"), and Catalyst Bank, a federally-chartered savings bank and wholly-owned subsidiary of Catalyst Bancorp, entered into an Agreement and Plan of Share Exchange and Merger (the “Merger Agreement”) with Lakeside Bancshares, Inc., a Louisiana corporation ("Lakeside Bancshares"), and Lakeside Bank, a Louisiana banking corporation and the wholly-owned subsidiary of Lakeside Bancshares.”

Corebridge Financial, Inc. entered into Voting and Support Agreement with Nippon Life Insurance Company and Equitable Holdings, Inc. (effective 2026-04-08).

“On April 8, 2026, Corebridge Financial, Inc., a Delaware corporation (“Corebridge”), entered into a Voting and Support Agreement (the “Voting and Support Agreement”) with Nippon Life Insurance Company, a mutual company ( sougogaisha ) organized under the laws of Japan (“Nippon Life”), and Equitable Holdings, Inc., a Delaware corporation (“Equitable”) in connection with the previously announced Agreement and Plan of Merger (the “Merger Agreement”), dated as of March 26, 2026”

New ERA Energy & Digital, Inc. entered into Term Loan Agreement with Macquarie Equipment Capital Inc. valued at up to $290,000,000 (effective 2026-04-08).

“On April 8, 2026, Texas Critical Data Centers LLC, a Delaware limited liability company (the “Borrower”), a subsidiary of New Era Energy & Digital, Inc., a Nevada corporation (the “Company” or “New Era”), entered into a Term Loan Agreement (the “Term Loan Agreement”) with Macquarie Equipment Capital Inc., a Delaware corporation (“Macquarie”), acting as administrative agent and lender (the “Lender”).”

DOMINION ENERGY, INC amended Sustainability Revolving Credit Agreement with Sumitomo Mitsui Banking Corporation valued at Extends maturity date to April 7, 2029 and provides for up to two additional one-year extensions (effective 2026-04-07).

“On April 7, 2026, Dominion Energy, Inc. (Dominion Energy) entered into an amendment to its existing Sustainability Revolving Credit Agreement, dated as of June 9, 2021 (the Sustainability Credit Agreement), with Sumitomo Mitsui Banking Corporation, as administrative agent, and the other agents and lenders party thereto.”

ODYSSEY MARINE EXPLORATION INC entered into Agreement and Plan of Merger with American Ocean Minerals Corporation (effective 2026-04-08).

“On April 8, 2026, Odyssey Marine Exploration, Inc. (“Odyssey”), Oceanus Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Odyssey (“Merger Sub”), and American Ocean Minerals Corporation, a Delaware corporation (“AOM,” and together with Odyssey and Merger Sub, the “Parties”), entered into an Agreement and Plan of Merger (the “Merger Agreement”)”

GT Biopharma, Inc. entered into Investigator Initiated Clinical Trial Agreement with the Regents of the University of Minnesota valued at up to approximately $3.8 million (effective 2026-04-03).

“On April 3, 2026, GT Biopharma, Inc., a Delaware corporation (the “Company”), entered into an Investigator Initiated Clinical Trial Agreement (the “Agreement”) with the Regents of the University of Minnesota (the “University”), pursuant to which, the University shall sponsor an Investigational New Drug (“IND”) application for IND 169118 GTB-5550 (the “Research Program”) and shall serve as a sponsor investigator for a phase 1a/1b clinical trial entitled, “GTB-5550, a Camelid Nanobody B7-H3 Tri-Specific Killer Engager (camB7-H3 TriKE®), in Select Advanced Solid Tumors That Failed Prior Therapy,” designed by University (the “Study”).”

FLOWERS FOODS INC entered into Revolver Amendment with Wells Fargo Bank, National Association valued at First Amendment to Credit Agreement extending Covenant Holiday through fiscal quarter ending October (effective 2026-04-06).

“on April 6, 2026, the Company entered into the First Amendment (the “Revolver Amendment”) to the Credit Agreement, dated as of February 5, 2025, with certain financial institutions party thereto as lenders and Wells Fargo Bank, National Association, as administrative agent”

FLOWERS FOODS INC entered into 2026 Term Loan Credit Agreement with Wells Fargo Bank, National Association valued at $400,000,000 senior unsecured delayed draw term loan credit facility (effective 2026-04-06).

“on April 6, 2026, Flowers Foods, Inc., a Georgia corporation (the “Company”), entered into a $400.0 million senior unsecured delayed draw term loan credit facility (the “2026 Term Loan Facility”)”

Prairie Operating Co. amended Amendment and Restatement of Amendment to Securities Purchase Agreement and Form of Anniversary Warrant with each of the investors listed on the Schedule of Buyers attached thereto (collectively, the "Buyers") valued at $3 million (effective 2026-04-06).

“On April 6, 2026, the Company and the Buyers entered into an Amendment and Restatement of Amendment to Securities Purchase Agreement and Form of Anniversary Warrant (the “Amendment”).”

NABORS INDUSTRIES LTD amended Incremental Joinder to the A&R Credit Agreement with BOKF, NA dba Bank of Texas, the issuing banks party thereto and Citibank, N.A., as administrative agent valued at $25,000,000 (effective 2026-04-07).

“On April 7, 2026, Nabors Industries, Inc. (“Nabors Delaware”), a wholly owned subsidiary of Nabors Industries Ltd. (the “Company”), and the Company entered into an Incremental Joinder to the A&R Credit Agreement (the “Joinder”), among themselves, BOKF, NA dba Bank of Texas, as the incremental letters of credit facility participant, the issuing banks party thereto and Citibank, N.A., as administrative agent, joining to and amending the amended and restated credit agreement dated June 17, 2024 (as amended, restated, supplemented or otherwise modified prior to April 7, 2026, the “A&R Credit Agreement”), among Nabors Delaware, the Company, the other guarantors from time to time party thereto, the revolving lenders, the letter of credit facility participants, the issuing banks and other lenders party thereto and Citibank, N.A., as administrative agent.”

Opus Genetics, Inc. entered into Note Purchase Agreement with OPCM SA LLC valued at up to $155 million (effective 2026-04-02).

“On April 2, 2026, Opus Genetics, Inc., a Delaware corporation (the “Company”), and certain of its subsidiaries as guarantors, entered into a senior secured note purchase agreement (the “Note Purchase Agreement”) with OPCM SA LLC, as purchaser agent (“Purchaser Agent”), and certain purchasers party thereto (the “Purchasers”).”

SUPERNUS PHARMACEUTICALS, INC. entered into Asset Purchase Agreement with Navitor Pharmaceuticals, Inc., Navitor Pharmaceuticals, LLC valued at up to $350 million (effective 2026-04-01).

“On April 1, 2026, Supernus Pharmaceuticals, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “Agreement”), together with related ancillary transaction documents, with Navitor Pharmaceuticals, Inc., a Delaware corporation (“Navitor”), Navitor Pharmaceuticals, LLC, a Delaware limited liability company (“Navitor Parent,” and, together with Navitor, the “Sellers”).”

KIORA PHARMACEUTICALS INC entered into Securities Purchase Agreement with certain institutional investors valued at expected aggregate gross proceeds at closing of approximately $5.0 million and potential future warr (effective 2026-04-03).

“On April 3, 2026, Kiora Pharmaceuticals, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain institutional investors (the “Purchasers”),”

Transportation & Logistics Systems, Inc. entered into Member Interest and Asset Exchange Agreement with Badcer Ops, Inc., Jeff Badders, Mercer Street Global Opportunity Fund, LLC, Patriot Glass Solutions, LLC, and Michael Wanke valued at $4,750,000 (effective 2026-04-01).

“Transportation and Logistics Systems, Inc. (OTC OID: TLSS), (“TLSS” or the “Company”), a publicly traded holding company, announced that, on April 1, 2026, the Company, TLSS Acquisition, Inc., a wholly-owned subsidiary of the Company, (the “Acquisition Sub”), and TLSS Reverse PGS, LLC, a Texas limited liability company and a wholly-owned subsidiary of the Acquisition Sub (“Reverse”), entered into a Member Interest and Asset Exchange Agreement (the “Agreement”) with Badcer Ops, Inc., a Nevada corporation (the “Seller”), Jeff Badders and Mercer Street Global Opportunity Fund, LLC, a Delaware limited liability company (“Mercer”), as the shareholders of the Seller (the “Seller Shareholders”), Patriot Glass Solutions, LLC, a Texas limited liability company (“PGS”), and Michael Wanke (“Wanke”), the sole Manager and twenty percent (20%) owner of PGS.”

NXG NextGen Infrastructure Income Fund entered into Dealer Manager Agreement with UBS Securities LLC (effective 2026-04-06).

“On April 6, 2026, NXG NextGen Infrastructure Income Fund (the “Fund”) entered into a dealer manager agreement (the “Dealer Manager Agreement”) by and among the Fund, Cushing ® Asset Management, LP, d/b/a NXG Investment Management and UBS Securities LLC in connection with the issuance by the Fund to the holders of record (the “Record Date Shareholders”) at the close of business on April 6, 2026 (the “Record Date”) transferable rights”

Boxlight Corp amended Amended and Restated Agreement with J.J. Astor & Co. valued at $556,200 (effective 2026-04-01).

“On April 1, 2026, Boxlight Corporation, a Nevada corporation (the “Company”) entered into an amendment to that certain inventory finance agreement, dated May 27, 2025, as amended and restated on November 7, 2025, (as so amended through the date hereof, the “Amended and Restated Agreement”) with J.J. Astor & Co., a Utah corporation (“J.J. Astor”).”

FreeCast, Inc. amended Amendment to Equity Purchase Agreement with Amiens Technology Investments, LLC (effective 2026-03-30).

“On March 30, 2026, FreeCast, Inc., a Florida corporation (the “ Company, ” “ we ” or “ our ”) entered into an Amendment to Equity Purchase Agreement (the “ Amendment ”) with Amiens Technology Investments, LLC (the “ Investor ”).”

Four Corners Property Trust, Inc. entered into Loan Agreement with The Huntington National Bank as administrative agent, with Huntington and U.S. Bank, N.A. acting as Joint Bookrunners and Joint Lead Arrangers and additional lenders included Fifth Third Bank, N.A. which acted as Joint Lead Arranger and Raymond James Bank which acted as Documentation Agent valued at $200.0 million (effective 2026-04-06).

“On April 6, 2026 (the “Closing Date”), Four Corners Property Trust, Inc. (the “Company”) and its subsidiary, Four Corners Operating Partnership, LP (the “Borrower”), entered into a Term Loan Agreement (the “Loan Agreement”) with The Huntington National Bank ("Huntington") as administrative agent, with Huntington and U.S. Bank, N.A. acting as Joint Bookrunners and Joint Lead Arrangers and additional lenders included Fifth Third Bank, N.A. which acted as Joint Lead Arranger and Raymond James Bank which acted as Documentation Agent (the “Lenders”).”

New Fortress Energy Inc. entered into Master Lease Agreement with Macquarie Energy LLC (effective 2026-04-01).

“NFE Turbines LLC (“Lessee”), a subsidiary of the Company, entered into a Master Lease Agreement (together with the applicable schedules, riders and other lease documents, the “Lease”), pursuant to which the parties agreed to consummate a sale and leaseback transaction (the “Sale-Leaseback Transaction”) with respect to certain turbines (the “Equipment”).”

New Fortress Energy Inc. entered into Asset Purchase Agreement with Macquarie Energy LLC valued at $265,882,500.00 (effective 2026-04-01).

“On April 1, 2026, NFE Power PR LLC (“Seller”), a subsidiary of New Fortress Energy Inc. (the “Company”), entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Macquarie Energy LLC (“Macquarie"),”

TCW Direct Lending VIII LLC amended Amendment No. 5 to its Amended and Restated Limited Liability Company Agreement (effective 2026-04-01).

“On April 1, 2026, in connection with the completion of the Exchange Offer (as defined below), TCW Direct Lending VIII LLC (the “Company”) entered into Amendment No. 5 to its Amended and Restated Limited Liability Company Agreement (the “LLCA Amendment”).”

Transcode Therapeutics, Inc. entered into Standby Equity Purchase Agreement with YA II PN, LTD valued at $14 million (effective 2026-04-06).

“On April 6, 2026 , TransCode Therapeutics, Inc., a Delaware corporation, (the “Company,” “we,” or “our”) entered into a Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, LTD, a Cayman Islands exempt limited partnership (“Yorkville”), pursuant to which the Company has the right to sell to Yorkville up to $14 million of shares of the Company’s common stock”

AB Commercial Real Estate Private Debt Fund, LLC amended Second Amendment to Fee Letter with Citibank, N.A. valued at increased the Facility Amount from $258,220,000 to $500,000,000 (effective 2026-04-01).

“On April 1, 2026, PDF entered into an amendment (the “ Fee Letter Amendment ”) to the fee letter (as amended, the “ Fee Letter ”), dated as of April 1, 2025, as amended by that certain First Amendment to Fee Letter, dated as of February 26, 2026, by and among PDF, as Seller, the Company, as Guarantor, and Citibank, as Buyer. The Fee Letter Amendment increased the Facility Amount (as defined in the Fee Letter) under the Fee Letter from $258,220,000 to $500,000,000.”

AB Commercial Real Estate Private Debt Fund, LLC amended First Amendment to Master Repurchase Agreement with Citibank, N.A. valued at extends the Stated Termination Date from April 1, 2027 to April 1, 2028 (effective 2026-04-01).

“On April 1, 2026, AB CRE PDF Lending C LLC (“ PDF ”), a wholly-owned subsidiary of AB Commercial Real Estate Private Debt Fund, LLC (the “ Company ”), entered into an amendment (the “ MRA Amendment ”) to the Master Repurchase Agreement and Securities Contract (the “ Repurchase Agreement ”), by and among PDF, as Seller, the Company, as Guarantor, and Citibank, N.A. (“ Citibank ”), as Buyer. The MRA Amendment, among other changes, extends the Stated Termination Date (as defined in the Repurchase Agreement) under the Repurchase Agreement from April 1, 2027 to April 1, 2028.”

RICHTECH ROBOTICS INC. entered into Purchase and Sale Agreement with PSIF EBS Rainbow LLC valued at $21,180,000.00 (effective 2026-04-01).

“On April 1, 2026 (the “ Effective Date ”), Richtech Robotics Inc., a Nevada corporation (the “ Company ”), entered into a purchase and sale agreement (the “ Purchase and Sale Agreement ”) with PSIF EBS Rainbow LLC, a Delaware limited liability company (the “ Seller ”), with respect to the purchase of property, as described in more detail in the Purchase and Sale Agreement, including an approximately 79,325 square foot building located at 9530 S. Rainbow Blvd., Las Vegas, Nevada 89139 (the “ Property ”).”

Haymaker Acquisition Corp. 4 entered into Forward Purchase Agreement with Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP valued at Prepayment Amount equal to number of Shares multiplied by per-share redemption price at closing of B (effective 2026-04-06).

“On April 6, 2026, Haymaker and Pubco entered into a forward purchase agreement (the “Forward Purchase Agreement”) with each of Harraden Circle Investors, LP (“HCI”), Harraden Circle Special Opportunities, LP (“HCSO”), Harraden Circle Strategic Investments, LP (“HCSI”) and Harraden Circle Concentrated, LP (“HCC”) (with HCI, HCSO, HCSI, HCC, collectively as “Seller”) for a prepaid share forward transaction.”

Haymaker Acquisition Corp. 4 entered into Non-Redemption Agreement with existing shareholder valued at 250,000 Class A ordinary shares; cash payment equal to excess of redemption price per share over $10 (effective 2026-04-01).

“On April 1, 2026, Haymaker entered into a Non-Redemption Agreement (the “Non-Redemption Agreement”) with an existing shareholder of Haymaker, pursuant to which, among other things, the investor agreed to reverse its election to redeem 250,000 Class A ordinary shares of Haymaker, par value $0.0001 per share (the “Holder’s Shares”), initially included as part of the units sold in Haymaker’s initial public offering (the “Public Shares”), to waive their redemption rights, vote in favor of the Business Combination at the Shareholder Meeting (as defined below), and hold the Holder’s Shares through the closing date of the Business Combination.”

Wellgistics Health, Inc. entered into Note Purchase Agreement with certain investors valued at up to $1,250,000 in aggregate principal amount (effective 2026-04-01).

“On April 1, 2026, Wellgistics Health, Inc. (the “Company”), entered into a note purchase agreement (the “Note Purchase Agreement”) with certain investors (the “Investors”) whereby the Company agreed to issue and sell to the Investors in a private offering up to $1,250,000 in aggregate principal amount (the “Aggregate Principal Amount”) of promissory notes (the “Notes”) (the “Offering”).”